Eversept Partners, LP
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 17, 2026), Eversept Partners, LP reported 103 stock positions worth $1.8 billion. Its top holding was Vera Therapeutics (VERA) at 8.7% of the portfolio, followed by GSK PLC-Spon ADR (GSK, 7.4%) and United Therapeutics (UTHR, 6.9%). Compared with Q3 2025, it opened 34 new positions, sold out of 14, added to 37 and reduced 30. The biggest buy was Vera Therapeutics (VERA, shares +9%) and the biggest sale Uniqure (QURE, shares −93%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001697013
- Portfolio Value
- $1.8B (Q4 2025)
- SEC Filing
- 0001697013-26-000002 ↗ filed Feb 17, 2026
Holdings Value
Holdings 103 stocks · $1.8B
| VERA Vera Therapeutics Inc. | 8.72% | 3,072,304 | $155.6M | Add +9.4% |
| GSK GSK PLC-Spon ADR | 7.37% | 2,679,721 | $131.4M | Add +26.4% |
| UTHR United Therapeutics Corp. | 6.90% | 252,592 | $123.1M | Reduce -0.3% |
| ABVX Abivax SA-ADR | 4.97% | 657,834 | $88.7M | Add +54.2% |
| NTRA Natera Inc. | 4.30% | 334,493 | $76.6M | Reduce -35.6% |
| SNDX Syndax Pharmaceuticals Inc. | 3.90% | 3,314,408 | $69.6M | Reduce -4.4% |
| VRDN Viridian Therapeutics Inc. | 3.11% | 1,782,235 | $55.5M | Reduce -7.4% |
| PCVX Vaxcyte Inc. | 3.10% | 1,197,722 | $55.3M | Reduce -15.8% |
| TVTX Travere Therapeutics Inc. | 2.52% | 1,174,968 | $44.9M | Reduce -17.1% |
| HCA HCA Healthcare Inc. | 2.51% | 95,874 | $44.8M | Reduce -14.2% |
| DHR Danaher Corp. | 2.39% | 186,262 | $42.6M | Add +87.6% |
| IONS Ionis Pharmaceuticals Inc. | 2.39% | 538,218 | $42.6M | Reduce -0.1% |
| CLDX Celldex Therapeutics Inc. | 2.19% | 1,434,725 | $39.0M | Add +24.3% |
| BRKR Bruker Corp. | 2.07% | 783,789 | $36.9M | Add +14.1% |
| AVTR Avantor Inc. | 2.04% | 3,176,644 | $36.4M | Add +243.6% |
| CYH Community Health Systems Inc. | 1.39% | 7,943,802 | $24.8M | Add +14.3% |
| EXAS Exact Sciences Corp. | 1.38% | 241,678 | $24.5M | New |
| BCRX Biocryst Pharmaceuticals Inc. | 1.31% | 2,992,895 | $23.3M | Add +117.9% |
| GERN Geron Corp. | 1.31% | 17,659,983 | $23.3M | Add +40.2% |
| TECH Bio-Techne Corp. | 1.24% | 377,405 | $22.2M | Reduce -36.2% |
| CDTX Cidara Therapeutics Inc. | 1.22% | 98,721 | $21.8M | New |
| PODD Insulet Corp. | 1.19% | 74,708 | $21.2M | Add +63.8% |
| BBNX Beta Bionics Inc. | 1.16% | 678,262 | $20.7M | New |
| TEVA Teva Pharmaceutical-SP ADR | 1.16% | 660,177 | $20.6M | Reduce -51.6% |
| UNH Unitedhealth Group Inc. | 1.13% | 60,862 | $20.1M | Reduce -3.1% |
| LQDA Liquidia Corp. | 0.99% | 509,443 | $17.6M | Add +4.8% |
| ICLR Icon PLC | 0.98% | 95,832 | $17.5M | Add +74.2% |
| HQY Healthequity Inc. | 0.95% | 185,739 | $17.0M | Add +254.5% |
| GKOS Glaukos Corp. | 0.93% | 147,471 | $16.7M | New |
| RVTY Revvity Inc. | 0.88% | 162,777 | $15.7M | Reduce -58.7% |
| NAMS Newamsterdam Pharma Co. NV | 0.83% | 420,827 | $14.8M | Reduce -13.9% |
| ESPR Esperion Therapeutics Inc. | 0.80% | 3,851,133 | $14.2M | New |
| BIIB Biogen Inc. | 0.77% | 77,944 | $13.7M | Add +50.6% |
| SEM Select Medical Holdings Corp. | 0.75% | 906,100 | $13.5M | New |
| CNC Centene Corp. | 0.75% | 324,092 | $13.3M | Add +44.3% |
| CGON CG Oncology Inc. | 0.72% | 308,466 | $12.8M | New |
| BMY Bristol-Myers Squibb Co. | 0.71% | 235,293 | $12.7M | New |
| PALI Palisade Bio Inc. | 0.71% | 5,391,548 | $12.7M | New |
| ARQT Arcutis Biotherapeutics Inc. | 0.71% | 434,634 | $12.6M | Add +289.9% |
| PHVS Pharvaris NV | 0.68% | 439,177 | $12.2M | New |
| LLY Eli Lilly & Co. | 0.64% | 10,623 | $11.4M | New |
| EHC Encompass Health Corp. | 0.64% | 106,926 | $11.3M | New |
| CTMX Cytomx Therapeutics Inc. | 0.60% | 2,507,090 | $10.7M | New |
| ELV Elevance Health Inc. | 0.59% | 30,195 | $10.6M | Reduce -32.9% |
| MNKD Mannkind Corp. | 0.59% | 1,852,563 | $10.5M | Reduce -9.3% |
| XENE Xenon Pharmaceuticals Inc. | 0.58% | 231,380 | $10.4M | New |
| ASND Ascendis Pharma A/S | 0.58% | 48,241 | $10.3M | New |
| ISRG Intuitive Surgical Inc. | 0.57% | 18,062 | $10.2M | Add +25.2% |
| ILMN Illumina Inc. | 0.56% | 76,721 | $10.1M | Reduce -38.0% |
| ARDX Ardelyx Inc. | 0.56% | 1,715,129 | $10.0M | Add +20.0% |
| DVAX Dynavax Technologies Corp. | 0.52% | 605,976 | $9.3M | Reduce -12.6% |
| GPCR Structure Therapeutics Inc. | 0.50% | 127,561 | $8.9M | Reduce -23.3% |
| EWTX Edgewise Therapeutics Inc. | 0.47% | 337,340 | $8.4M | Reduce -32.8% |
| CPRX Catalyst Pharmaceuticals Inc. | 0.47% | 358,168 | $8.4M | Add +2.1% |
| HUM Humana Inc. | 0.47% | 32,462 | $8.3M | Add +94.9% |
| PNTG The Pennant Group Inc. | 0.46% | 293,960 | $8.3M | Add +674.0% |
| MRNA Moderna Inc. | 0.44% | 267,823 | $7.9M | New |
| MOH Molina Healthcare Inc. | 0.44% | 45,470 | $7.9M | Add +380.1% |
| REGN Regeneron Pharmaceuticals | 0.44% | 10,097 | $7.8M | Reduce -39.6% |
| TYRA Tyra Biosciences Inc. | 0.41% | 278,564 | $7.3M | Add +2.1% |
| RARE Ultragenyx Pharmaceutical Inc. | 0.41% | 317,182 | $7.3M | New |
| ANAB Anaptysbio Inc. | 0.33% | 120,927 | $5.9M | New |
| BMRN Biomarin Pharmaceutical Inc. | 0.31% | 93,748 | $5.6M | Reduce -36.1% |
| ASMB Assembly Biosciences Inc. | 0.30% | 159,676 | $5.4M | New |
| IVVD Invivyd Inc. | 0.30% | 2,140,130 | $5.3M | Add +4.5% |
| CVS CVS Health Corp. | 0.28% | 63,696 | $5.1M | New |
| ACAD Acadia Pharmaceuticals Inc. | 0.26% | 176,594 | $4.7M | Add +7.5% |
| PTGX Protagonist Therapeutics Inc. | 0.26% | 52,961 | $4.6M | New |
| ZBIO Zenas Biopharma Inc. | 0.25% | 121,016 | $4.4M | Reduce -23.8% |
| RLAY Relay Therapeutics Inc. | 0.23% | 489,137 | $4.1M | Add +2.1% |
| ENGN Engene Holdings Inc. | 0.23% | 455,835 | $4.1M | New |
| BKD Brookdale Senior Living Inc. | 0.23% | 374,929 | $4.0M | New |
| NHC National Healthcare Corp. | 0.22% | 28,577 | $3.9M | New |
| FTRE Fortrea Holdings Inc. | 0.22% | 224,139 | $3.9M | Add +2.2% |
| BVS Bioventus Inc. Class A | 0.20% | 471,257 | $3.5M | Add +8.6% |
| SPRY Ars Pharmaceuticals Inc. | 0.16% | 251,593 | $2.9M | Reduce -74.2% |
| AVR Anteris Technologies Global | 0.14% | 500,000 | $2.5M | No change |
| AMRN Amarin Corp. PLC -ADR | 0.13% | 172,188 | $2.4M | Add +2.9% |
| MRVI Maravai Lifesciences Hldgs-A | 0.13% | 718,582 | $2.3M | Add +147.2% |
| EOLS Evolus Inc. | 0.13% | 344,104 | $2.3M | Reduce -76.7% |
| STRO Sutro Biopharma Inc. | 0.13% | 193,571 | $2.2M | Reduce -15.5% |
| SRZN Surrozen Inc. | 0.12% | 95,286 | $2.2M | Add +23.8% |
| EHAB Enhabit Inc. | 0.11% | 218,510 | $2.0M | New |
| RAPP Rapport Therapeutics Inc. | 0.10% | 59,233 | $1.8M | Reduce -58.7% |
| IFRX Inflarx NV | 0.10% | 1,757,312 | $1.8M | Add +1.5% |
| BHVN Biohaven Ltd. | 0.09% | 145,431 | $1.6M | New |
| CTNM Contineum Therapeutics Inc. Class A | 0.09% | 137,493 | $1.6M | Add +2.1% |
| ALEC Alector Inc. | 0.09% | 1,006,163 | $1.6M | Reduce -32.4% |
| NVCR Novocure Ltd. | 0.09% | 120,978 | $1.6M | New |
| QURE Uniqure NV | 0.08% | 62,820 | $1.5M | Reduce -92.8% |
| PASG Passage Bio Inc. | 0.08% | 126,230 | $1.5M | New |
| BCYC Bicycle Therapeutics PLC-ADR | 0.07% | 178,915 | $1.3M | Reduce -8.0% |
| NVAX Novavax Inc. | 0.07% | 181,220 | $1.2M | Reduce -25.5% |
| PLRX Pliant Therapeutics Inc. | 0.06% | 842,023 | $1.0M | Add +2.1% |
| SVRA Savara Inc. | 0.06% | 170,195 | $1.0M | New |
| EHTH Ehealth Inc. | 0.06% | 222,570 | $1.0M | Add +73.5% |
| INMD Inmode Ltd. | 0.05% | 61,938 | $910K | New |
| WHWK Whitehawk Therapeutics Inc. | 0.04% | 260,259 | $630K | New |
| EDIT Editas Medicine Inc. | 0.03% | 290,919 | $596K | New |
| SLQT Selectquote Inc. | 0.03% | 357,661 | $504K | New |
Options reported separately and not counted above: QQQ puts ($138.2M), SPY puts ($30.6M), TLT puts ($20.0M), XBI puts ($12.1M).
Portfolio Sells Q3 2025 → Q4 2025
| QURE Uniqure NV | Reduce -92.8% | 0.08% | −3.84 |
| ZIMV Zimvie Inc. | Sold out | 0.00% | −3.02 |
| NTRA Natera Inc. | Reduce -35.6% | 4.30% | −2.11 |
| RVTY Revvity Inc. | Reduce -58.7% | 0.88% | −1.76 |
| TECH Bio-Techne Corp. | Reduce -36.2% | 1.24% | −1.28 |
| UTHR United Therapeutics Corp. | Reduce -0.3% | 6.90% | −1.23 |
| HCA HCA Healthcare Inc. | Reduce -14.2% | 2.51% | −1.14 |
| RGEN Repligen Corp. | Sold out | 0.00% | −1.08 |
| RNAM Avidity Biosciences Inc. | Sold out | 0.00% | −1.01 |
| TEVA Teva Pharmaceutical-SP ADR | Reduce -51.6% | 1.16% | −0.95 |
| NVO Novo-Nordisk A/S-Spons ADR | Sold out | 0.00% | −0.93 |
| PCVX Vaxcyte Inc. | Reduce -15.8% | 3.10% | −0.82 |
| SPRY Ars Pharmaceuticals Inc. | Reduce -74.2% | 0.16% | −0.59 |
| EOLS Evolus Inc. | Reduce -76.7% | 0.13% | −0.57 |
| UNH Unitedhealth Group Inc. | Reduce -3.1% | 1.13% | −0.53 |
| ELV Elevance Health Inc. | Reduce -32.9% | 0.59% | −0.52 |
| ETNB 89BIO Inc. | Sold out | 0.00% | −0.44 |
| MRUS Merus NV | Sold out | 0.00% | −0.35 |
| ILMN Illumina Inc. | Reduce -38.0% | 0.56% | −0.34 |
| IONS Ionis Pharmaceuticals Inc. | Reduce -0.1% | 2.39% | −0.31 |
| BMRN Biomarin Pharmaceutical Inc. | Reduce -36.1% | 0.31% | −0.30 |
| REGN Regeneron Pharmaceuticals | Reduce -39.6% | 0.44% | −0.28 |
| MIRM Mirum Pharmaceuticals Inc. | Sold out | 0.00% | −0.28 |
| MNKD Mannkind Corp. | Reduce -9.3% | 0.59% | −0.25 |
| ALEC Alector Inc. | Reduce -32.4% | 0.09% | −0.25 |
| NAMS Newamsterdam Pharma Co. NV | Reduce -13.9% | 0.83% | −0.24 |
| RAPP Rapport Therapeutics Inc. | Reduce -58.7% | 0.10% | −0.23 |
| NKTR Nektar Therapeutics | Sold out | 0.00% | −0.22 |
| GOSS Gossamer Bio Inc. | Sold out | 0.00% | −0.19 |
| SNDX Syndax Pharmaceuticals Inc. | Reduce -4.4% | 3.90% | −0.18 |
| KURA Kura Oncology Inc. | Sold out | 0.00% | −0.18 |
| EWTX Edgewise Therapeutics Inc. | Reduce -32.8% | 0.47% | −0.15 |
| NVAX Novavax Inc. | Reduce -25.5% | 0.07% | −0.09 |
| TVTX Travere Therapeutics Inc. | Reduce -17.1% | 2.52% | −0.08 |
| KRRO Korro Bio Inc. | Sold out | 0.00% | −0.08 |
| VRDN Viridian Therapeutics Inc. | Reduce -7.4% | 3.11% | −0.07 |
| PVLA Palvella Therapeutics Inc. | Sold out | 0.00% | −0.05 |
| BCYC Bicycle Therapeutics PLC-ADR | Reduce -8.0% | 0.07% | −0.04 |
| STRO Sutro Biopharma Inc. | Reduce -15.5% | 0.13% | −0.03 |
| ZBIO Zenas Biopharma Inc. | Reduce -23.8% | 0.25% | −0.02 |
| REPL Replimune Group Inc. | Sold out | 0.00% | −0.02 |
| DYN Dyne Therapeutics Inc. | Sold out | 0.00% | −0.01 |
| DVAX Dynavax Technologies Corp. | Reduce -12.6% | 0.52% | −0.00 |
| GPCR Structure Therapeutics Inc. | Reduce -23.3% | 0.50% | +0.14 |
Portfolio Buys Q3 2025 → Q4 2025
| VERA Vera Therapeutics Inc. | Add +9.4% | 8.72% | +2.47 |
| ABVX Abivax SA-ADR | Add +54.2% | 4.97% | +2.20 |
| EXAS Exact Sciences Corp. | New | 1.38% | +1.38 |
| CDTX Cidara Therapeutics Inc. | New | 1.22% | +1.22 |
| BBNX Beta Bionics Inc. | New | 1.16% | +1.16 |
| AVTR Avantor Inc. | Add +243.6% | 2.04% | +1.16 |
| GKOS Glaukos Corp. | New | 0.93% | +0.93 |
| DHR Danaher Corp. | Add +87.6% | 2.39% | +0.88 |
| ESPR Esperion Therapeutics Inc. | New | 0.80% | +0.80 |
| SEM Select Medical Holdings Corp. | New | 0.75% | +0.75 |
| CGON CG Oncology Inc. | New | 0.72% | +0.72 |
| BMY Bristol-Myers Squibb Co. | New | 0.71% | +0.71 |
| PALI Palisade Bio Inc. | New | 0.71% | +0.71 |
| PHVS Pharvaris NV | New | 0.68% | +0.68 |
| LLY Eli Lilly & Co. | New | 0.64% | +0.64 |
| EHC Encompass Health Corp. | New | 0.64% | +0.64 |
| CTMX Cytomx Therapeutics Inc. | New | 0.60% | +0.60 |
| XENE Xenon Pharmaceuticals Inc. | New | 0.58% | +0.58 |
| ASND Ascendis Pharma A/S | New | 0.58% | +0.58 |
| HQY Healthequity Inc. | Add +254.5% | 0.95% | +0.57 |
| ARQT Arcutis Biotherapeutics Inc. | Add +289.9% | 0.71% | +0.55 |
| BCRX Biocryst Pharmaceuticals Inc. | Add +117.9% | 1.31% | +0.51 |
| MRNA Moderna Inc. | New | 0.44% | +0.44 |
| RARE Ultragenyx Pharmaceutical Inc. | New | 0.41% | +0.41 |
| PNTG The Pennant Group Inc. | Add +674.0% | 0.46% | +0.39 |
| BRKR Bruker Corp. | Add +14.1% | 2.07% | +0.36 |
| GSK GSK PLC-Spon ADR | Add +26.4% | 7.37% | +0.36 |
| ANAB Anaptysbio Inc. | New | 0.33% | +0.33 |
| ASMB Assembly Biosciences Inc. | New | 0.30% | +0.30 |
| MOH Molina Healthcare Inc. | Add +380.1% | 0.44% | +0.30 |
| CVS CVS Health Corp. | New | 0.28% | +0.28 |
| PTGX Protagonist Therapeutics Inc. | New | 0.26% | +0.26 |
| ICLR Icon PLC | Add +74.2% | 0.98% | +0.24 |
| ENGN Engene Holdings Inc. | New | 0.23% | +0.23 |
| BKD Brookdale Senior Living Inc. | New | 0.23% | +0.23 |
| NHC National Healthcare Corp. | New | 0.22% | +0.22 |
| BIIB Biogen Inc. | Add +50.6% | 0.77% | +0.21 |
| LQDA Liquidia Corp. | Add +4.8% | 0.99% | +0.14 |
| HUM Humana Inc. | Add +94.9% | 0.47% | +0.13 |
| CNC Centene Corp. | Add +44.3% | 0.75% | +0.13 |
| IVVD Invivyd Inc. | Add +4.5% | 0.30% | +0.12 |
| TYRA Tyra Biosciences Inc. | Add +2.1% | 0.41% | +0.12 |
| EHAB Enhabit Inc. | New | 0.11% | +0.11 |
| PODD Insulet Corp. | Add +63.8% | 1.19% | +0.11 |
| BHVN Biohaven Ltd. | New | 0.09% | +0.09 |
| NVCR Novocure Ltd. | New | 0.09% | +0.09 |
| PASG Passage Bio Inc. | New | 0.08% | +0.08 |
| ISRG Intuitive Surgical Inc. | Add +25.2% | 0.57% | +0.08 |
| FTRE Fortrea Holdings Inc. | Add +2.2% | 0.22% | +0.08 |
| MRVI Maravai Lifesciences Hldgs-A | Add +147.2% | 0.13% | +0.07 |
Options Activity Q3 2025 → Q4 2025
| QQQ Invesco QQQ Trust Series 1 | put | Reduce -2.2% | 225,000 | $138.2M |
| SPY SS SPDR S&P 500 ETF Trust-US | put | New | 44,900 | $30.6M |
| TLT iShares 20+ Year Treasury BD | put | New | 230,000 | $20.0M |
| XBI SS SPDR S&P Biotech ETF | put | New | 99,400 | $12.1M |
| UTHR United Therapeutics Corp. | put | Sold out | 16,200 | $6.8Mbefore exit |
| ATYR Atyr Pharma Inc. | put | Sold out | 658,000 | $475Kbefore exit |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 115 | $1.8B | UTHR, ABVX, EHC, ENSG, VERA |
| Q1 2026 | 104 | $1.5B | UTHR, ABVX, GSK, VERA, NTRA |
| Q4 2025 | 103 | $1.8B | VERA, GSK, UTHR, ABVX, NTRA |
| Q3 2025 | 83 | $1.3B | UTHR, GSK, NTRA, VERA, SNDX |
| Q2 2025 | 67 | $992.2M | NTRA, GSK, VERA, RVTY, PCVX |
| Q1 2025 | 55 | $883.7M | NTRA, GSK, HCA, SNDX, VERA |
| Q4 2024 | 62 | $969.1M | NTRA, GSK, VERA, INSP, HCA |
| Q3 2024 | 65 | $1.3B | GSK, NTRA, VERA, INSM, SNDX |
| Q2 2024 | 72 | $1.3B | GSK, NTRA, INSM, TEVA, UTHR |
| Q1 2024 | 68 | $1.3B | NTRA, GSK, INSP, TEVA, VERA |